Midcontinent Livestock Supplements, Inc. – Trademark Portfolio

Entity Type: 03

Midcontinent Livestock Supplements, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include MLS. The owner is based in Moberly, MO.

2401 Highway DD

Moberly, MO 63105

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark
Serial #86052254
Registered 2013
MLS
MLS
Registered 2007
MLS
MLS
Cancelled 2001

Trademark Classifications

Midcontinent Livestock Supplements, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Midcontinent Livestock Supplements, Inc. have?

Midcontinent Livestock Supplements, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.

What trademark classes does Midcontinent Livestock Supplements, Inc. file in?

Midcontinent Livestock Supplements, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Midcontinent Livestock Supplements, Inc.'s most well-known trademarks?

Midcontinent Livestock Supplements, Inc.'s registered trademark portfolio includes well-known marks such as MLS. These are among 2 currently registered trademarks in the portfolio.

What is Midcontinent Livestock Supplements, Inc.'s trademark registration success rate?

Midcontinent Livestock Supplements, Inc. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.